Cargando…
Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
Worldwide, 50 million people suffer from dementia, a group of symptoms affecting cognitive and social functions, progressing severely enough to interfere with daily life. Alzheimer’s disease (AD) accounts for most of the dementia cases. Pathological and clinical findings have led to proposing severa...
Autores principales: | Tanaka, Masaru, Bohár, Zsuzsanna, Vécsei, László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036975/ https://www.ncbi.nlm.nih.gov/pubmed/32012948 http://dx.doi.org/10.3390/molecules25030564 |
Ejemplares similares
-
Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
por: Bohár, Zsuzsanna, et al.
Publicado: (2015) -
Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
por: Török, Nóra, et al.
Publicado: (2020) -
Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
por: Nagy-Grócz, Gábor, et al.
Publicado: (2017) -
Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway
por: Tanaka, Masaru, et al.
Publicado: (2021) -
Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
por: Tanaka, Masaru, et al.
Publicado: (2021)